Navigation Links
Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
Date:7/29/2008

SAN DIEGO, July 29 /PRNewswire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced it will report second quarter 2008 financial results after the NASDAQ Global Market closes on Tuesday, August 5, 2008. That same afternoon, Jack Lief, Arena's President and Chief Executive Officer, and Robert E. Hoffman, Arena's Vice President, Finance and Chief Financial Officer, will host a conference call at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) to discuss the second quarter 2008 financial results and to provide a corporate update.

The conference call may be accessed by dialing 877.419.6590 for domestic callers and 719.325.4872 for international callers. Please specify to the operator that you would like to join the "Arena Second Quarter Earnings Call." The conference call will be webcast live under the investor relations section of Arena's website at http://www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Arena Pharmaceuticals

Arena is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for the treatment of obesity. Arena's broad pipeline of novel compounds target G protein-coupled receptors, an important class of validated drug targets, and includes compounds being evaluated independentl
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
2. ThreeWire Expands Presence in the Pharmaceutical Arena
3. Arena Pharmaceuticals to Present at the Bank of America 2008 Healthcare Conference
4. Arena Pharmaceuticals Announces First Quarter 2008 Financial Results
5. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
7. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2007 Financial Results and to Host Conference Call and Webcast on Wednesday, February 27, 2008
8. Arena Pharmaceuticals to Present at the BIO CEO & Investor Conference
9. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Second Generation Niacin Receptor Agonist Under Its Collaboration With Merck & Co., Inc.
10. Arena Pharmaceuticals Enters Into Strategic Agreements for the Manufacture of Pharmaceutical Material, Including Lorcaserin
11. Arena Pharmaceuticals Initiates Second and Third Pivotal Trials Evaluating Lorcaserin for the Treatment of Obesity

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ES(Nasdaq: IESC ),aleadingnationalproviderofelectr...rcial,industrialandresidentialmarkets,announcedtod...tractfromManhattanTorconJVtoinstalltheelectricalsy...cilityattheU.S.ArmyMedicalResearchInstituteofInfec.... ,, ThenewUSAMRIIDreplacementfacilitywilladdap...
(Date:11/24/2009)...omoreprestigiousuniversitieshavejoinedBioCareerCen...forlifescienceprofessionals. ,, Northwesternand...ng28othermajorlifesciencetrainingInstitutions. ,...post-graduatesinthelifesciences.Whiletherearehundr...Centeristheonlyonethatserveslifesciencepost-gradua...
(Date:11/24/2009)...Sigma-AldrichCorporation(Nasdaq: SIAL )willbeprese...at1:45PMGMTinLondon,7:45AMUS/CST.Interestedparties...ableat http://inve s tor.sig m a a ldrich.c...e. ,, AboutSigma-Aldrich: Sigma-Aldrichisale...alandbiochemicalproductsandkitsareusedinscientific...
(Date:11/24/2009)...armaceuticalsInc.announced,theUSPatent&Tradema...nano-particleoraldeliveryorNODtechnology. , N...epeptidesor,proteinsintobio-adhesivenano-particles...sinjections.NODtechnologyisaplatformtechnology,tha...n,interferon,growthhormone,exenatide,heparinandmo...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...hted at the 14th Congress of the European Hematolo... Data in Breast Cancer to Be Presented at the Amer... , BETHESDA, Md., May 20 Micromet, Inc. (Nasdaq:...novel, proprietary antibodies for the treatment of...ay announced an oral(1) and a poster presentation(...
...ay 19 InfraReDx, Inc. announced today the first u...ses both light and sound to image coronary plaques.... Martin van der Ent performed the procedures on M...raphy at the Thoraxcenter. , , The combination ...RS imaging in a single study of the artery. IVUS ...
... , , ATLANTA, May 19 Meeting at the world,s lar...Kansas Bioscience Authority has approved more than...million initiative to help researchers and busines...s made at the Bio International Convention will cr...als and plant biology, expand cancer drug developm...
Other Biology Technology:Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 2Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 3Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 4Micromet to Present New Clinical Data on Blinatumomab at EHA and on Adecatumumab at ASCO 5First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 2First Use in Coronary Patients of a Combined Near-Infrared Spectroscopy and Ultrasound Imaging Catheter 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 2As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 3As Other States Pull Back, Kansas Accelerates Innovation Investments at Bio International Convention 4
(Date:11/23/2009)...y of New Hampshire microbiologist Louis Tisa has r...derstanding of the actinorhizal plants, widespread...or and contaminated soils. , The United States ...rofessor of molecular, cellular and biomedical sci...hip between the bacteria Frankia and Casuarina, an...
(Date:11/23/2009)...California biomedical engineer and cardiologist Tz...lp clinicians distinguish cardiac emergencies requ...geable with drugs and lifestyle change. , Angiog...rteries feeding the heart, offer an inside view of...sels, often revealing deposits of a dangerous fatt...
(Date:11/23/2009)... toads have existed for 360 million years and surv...fungus is threatening to make many of them extinct... Microbiology Today . , The fungus, Batrachoc...iated with waves of amphibian extinctions in Centr...,s. Bd infects over 350 amphibian species by penet...
Breaking Biology News(10 mins):UNH prof. receives nearly $500,000 to research environmentally significant plants 2Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 1Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 2Leading U S Expert Offers Ten Warning Signs and Symptoms of Mental Health Problems in Elderly 53497 3Martin Hensen head of e strategies UCB Germany 3A Making e marketing more than just an add on 9458 1The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace com 53495 1The Caryl Ehrlich Program Discusses Food Addiction on HealthyPlace com 53495 2
...ventive measure to patients in intensive care unit... has emerged from a study involving nearly sixthou...hers at University Medical Center (UMC) Utrecht ha...New England Journal of Medicine . , During the s... two kinds of antibiotic treatments with the stand...
...e seeds forces laboratory leukemia cells to commit...niversity of Kentucky. They found that within 24 h...being exposed to the extract. , The investigators..., issue of Clinical Cancer Research , a journal o...so teased apart the cell signaling pathway associa...
...tamin C or E or a combination of the supplements h...ake the supplements, according to data from a rand...issue of the Journal of the National Cancer Insti...hat people whose diets are high in fruits and vege...sk of cancer. Results from randomized trials that ...
Other Biology News:Fewer deaths with preventive antibiotic use 2Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds 2Vitamins C and E and beta carotene again fail to reduce cancer risk in randomized controlled trial 2
Mouse Anti-C1-inhibitor (C1-INH) Monoclonal Antibody, Unconjugated, Clone 8F3 from AntibodyShop A/S
...Certify products ATP-Free using Mo Bio luciferase ...ive ATP-Free certification service that will allow... level of accuracy and enable you to deliver them ... detection limit is 3.5 x 10-12 /l, which will all...
Mouse Anti-Human Choriongonadotropin (hCG) Monoclonal Antibody, Unconjugated, Clone 5F10 from AntibodyShop A/S
...Small Molecule Localization in Early Drug Developm...al drug compound localization data in early drug d...erys imaging mass spectrometry service maps unlab...s so you can localize drugs and metabolites prior ...
Biology Products: